Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
good luck
and thanks for clarifying the earlier post
proof?
Thanks
Thanks Slojab
Just a hunch but i think we'll hear more from the company this week. I think we may see a PR putting this 8k into context of the overall reorganization.
So this 8k contains the 2009 and 2010 filings for DMGM.
From the forward looking statement at the very end of the 2010 report it states the corporate actions that have transpired in 2011 to date.
*redomestication to delaware, name change to DMS florida inc
*DMS florida inc merges into DMSD (DMS merger subsidiary, Inc)
and thereafter with CMS
*CMS survived the merger and reorg
I recall Mike Grande's post on Nov 24:
When the years of paperwork to be caught up on are finnished, that a merger could be possible, the outcome by law would be a rebistribution of new shares to the existing stock holders!
Wake up everyone...We have an 8k
Great info - thanks. I just received this from Greenshift
Dear Shareholder:
As you may know, GreenShift Corporation common stock has historically traded on the Over the Counter Bulletin Board, or OTCBB.
A company called OTC Markets Group provides the primary venue for the quotation and trading of OTC securities today. This venue is an electronic interdealer quotation and trading system that is used by market makers, broker-dealers and ECNs. According to OTC Markets Group, this system provides an efficient and less expensive alternative to traditional, exchange-based markets for quotation and trading of stock in small public companies.
OTC Markets Group recently reorganized the OTC marketplace into three tiers according to the level of disclosure companies provide to investors and other criteria: OTCQX, OTCQB and OTC Pink. GreenShift Corporation has been assigned to the OTCQB tier, which is designed for smaller companies that are fully compliant and current in their reporting requirements.
We are given to understand that thousands of companies were moved to OTCQB during February 2011 as a result of the OTC Markets Group reorganization. We additionally understand that this reorganization has caused delays to occur in transfers of GreenShift Corporation common stock. We have no information regarding when these delays will be resolved, but believe the situation will self-correct.
GreenShift is a fully reporting company in full compliance with all applicable rules and regulations. We are aware of no other basis for any delay you may have experienced with respect to execution of your investment decisions involving GreenShift common stock.
Additional information regarding the OTC Markets Group reorganization and the OTCQB is available online at http://www.otcmarkets.com/otcqb/learn/market-structure.
Regards,
Investor Relations
GreenShift Corporation
This said don't you find it interesting that all the documents below dated Feb 18, Feb 19 and Feb 22 appear to have been created on Sunday the 27th and posted online shortly thereafter.
ok - thank you
yup. So we are
3/1/2011 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
Read this....
OTCBB Delistings and Rule 15c2-11: What Happened?
Jordan Posted in Stocks Tags: bulletin board, market makers, otcbb, OTCQB, Pink Sheets, Rule 15c2-11, Small-Cap Stock No Comments »
On February 15, 2011, below the radar of the financial community and with no publicity, they started dropping. First it was 48, then 4 on the following two days. Then on February 22, the floodgates opened and 569 companies were delisted from the OTC Bulletin Board and moved to the relatively new OTCQB, officially part of the OTC Market Group’s OTC Link quotation system. The reason given in each case? “Failure to comply with Rule 15c2-11.” What has changed so drastically in the past week, and why has it resulted in the sudden delisting of 622 OTCBB companies?
The reason isn’t that these companies have failed to meet certain quality standards or are delinquent in their reporting to the SEC. Quite the opposite – the OTCQB is a new market (launched in April 2010) for OTC-traded companies that are registered and current in their reporting obligations to the SEC, so a move from the BB to the QB by no means signals delinquency or lower reporting quality.
The root cause, as with almost any aspect of the financial world, comes down to money. All companies quoted on the OTCBB must maintain at least one registered market maker (see FAQ #14) to remain on the OTCBB. The issuer can’t voluntarily withdraw from the OTCBB, but when the last market maker withdraws from the stock, it is removed from the OTCBB after 4 days pursuant to Rule 15c2-11.
When this happens, the stock is usually quoted solely on the OTC Link system, rather than the typical dual BB/OTC Link quotation. The stock will trade on the OTCQB, the middle tier of the OTC marketplace reserved for fully reporting issuers that are quoted on one or both quotation platforms (Bulletin Board and OTC Link). The new OTC tier system classifies all OTC companies, whether quoted on the BB, OTC Link or both, into one of three tiers (OTCQX, OTCQB, or OTC Pink) based on the amount and quality of information they provide to investors. This tier system separates SEC-compliant issuers in the OTCQB tier from the speculative marketplace known as the “Pink Sheets” (now called “OTC Pink”), which is the bottom of the three tiers.
FINRA’s fee for OTCBB market makers is $6.00 per security traded during a given month. For market makers quoting hundreds of securities per month, these costs can quickly become prohibitive. According to the CCH Washington Service Bureau:
OTC Bulletin Board market markers [sic] are billed participation fees by The Financial Industry Regulatory Authority (FINRA) based on the number of positions during a given month. Because such fees have made it challenging for market maker firms to maintain markets in stocks that are not active, such firms are increasingly moving market making in OTCBB stocks from the OTCBB, which is a telephonic only market, to a new electronic interdealer quotation system [OTC Link] created by Pink OTC Markets, Inc. that lacks any participation fees. [Full article here]
One possible reason for the mass Bulletin Board delistings in the past week is that a large broker-dealer acting as the sole market maker for a number of stocks completely withdrew from the OTCBB, leaving hundreds of stocks, like this one, with no market maker and sending them to the OTC Markets four days later. This is difficult to prove, but a similar situation happened last year when major broker-dealer Knight Equity Markets stopped quoting securities on the phone-based, fee-laden OTCBB and switched primarily to the no-fee, electronic OTC Link.
The accompanying graphs, with data provided by www.otcbb.com, show a consistent and meaningful trend away from Bulletin Board quotations both in terms of the number of market makers participating and the number of securities quoted. More and more, it simply makes financial sense for market makers who quote a large number of securities to quote solely on the electronic OTC Markets and avoid the OTCBB participation fees.
Ted Campbell, CEO of GrowPublic, Inc., sums up the situation well:
It may take awhile for investors and issuers to come to the conclusion there is no real difference between an OTCBB® listed security and a Fully Reporting Issuer trading on the Pink Sheets now under the OTCQB designation. The recent move by many market makers to pull quotes on the OTCBB® platform causing a mass delisting to the Pink Sheets may be a precursor to the end of the importance of being listed on the OTCBB.
UPDATE (2/28/11): From OTCBB.com – FINRATM is updating the comment on the OTCBB Daily List used to indicate an issue is no longer eligible for quotation on the OTCBB due to a lack of quotation activity. The new comment will be “Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11”. This replaces the previous comment “Failure to comply with Rule 15c2-11”.
From the OTC markets website...notice the last entry.
Daily List Search
OTC BULLETIN BOARD (OTCBB) SYSTEM CHANGES
DIVIDENDS
Record Date Symbol Company Name Dividend Type
GERS Greenshift Corporation Common Stock Reverse Split
SYMBOL CHANGES
DL Date Date Old Symbol New Symbol/Name
8/20/2009 8/24/2009 GERS GERSE Greenshift Corporation Common Stock
NAME/SYMBOL CHANGES
DL Date Date Old Symbol/Name New Symbol/Name
8/9/2010 8/10/2010 GERS Greenshift Corporation Common Stock GERSD Greenshift Corporation NEW Common Stock
SECURITY DELETIONS
Dl Date Symbol Company Name Effective Date/Comments
3/1/2011 GERS Greenshift Corporation Common Stock 3/1/2011 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
Could it be a technical glitch related to the exchange promo?? I sent a note to the company in case they are unaware.
fyi - There is an ammended LOI and other correspondence on the Neuro-tech website.
Any News today?
great post.
Go VPRO
Really? And you don't think the majority shareholders Intas and Alpha would have anything to say about that in their contracts with Viropro??
...if Alpha is worth 21m and in return they were willing to accept approx 60% or VPRO - what does that imply VPRO is worth!
updated share structure:
*we have 185m owned by Intas
*soon to have 525m owned by Alpha (restricted for 6 months adn thereafter unrestricted but why would the majority shareholder start selling and thereby lose their majority shareholder status and privileges)
*50m owned by canadians who cannot deposit with brokerages
*Still leaves only about 100m free trading float
Johnkenny, VPRO does not need a R/S to accomplish their goals for exchange progression, as the company stated the goal is to
come back on the pink sheet fully disclosed. Then we will do whatever it’s needed to go back on the Bulletin Board and then we will start the process to get on a canadian market since most of Viropro investors are Canadian.
yes and bid at .057
Hard to find sellers at this price. There are very few float shares(3.75m) and shareholders(44 i think?) out there.
From VPRO Investor Relations:
Just heard back from IR at VPRO. My 2 questions and answers are below.
1. I see that Alpha has operations in both Malaysia and UK. Did we acquire the entire company of just the Malaysia manufacturing component?
The entire company.
6 months restricted.
From the company's most recent PR..
The company's board of directors has notified the Financial Regulatory Authority ("FINRA") and OTC Markets Group of the changes in the company's structure, and it is awaiting the update of its symbol and information on the OTC Markets' system.
As we await FINRA's issuance of a new symbol and recognition of the new name on the site of its primary quotation venue, it continues to trade over-the-counter under the symbol "DMGM."
Exactly. In the companies own words...
we are doing acquisitions in order to integrate our offer from the beginning of the process until the manufacturing and selling of the drugs.
This is the type of shareholder we like..their success is dependent upon ours.
What a deal(IMO)..for 21m we are getting the malay facility practically at cost.
Alpha Biologics Acquisition!
Shorten the production phase...means realizing revenues faster
SMART move VPRO!
http://www.alphabiologics.com/
NEWS!!!!!!!!!!!!!!
JMO but if you think they are a scam you can report them to the SEC. If the SEC feels the need to step in they will and have on other companies. They could get a suspension or revoked in worst case scenario. Those outcomes are not good for the shareholder but do protect anyone else from being harmed. There is civil action you could take if you wanted to seek restitution for losses.
good luck
It has already been established that there is no Auric in Spain!
I think this is why we have the due diligence period. MRES attorneys are reveiwing the offer and the ability of Auric to pay.
This is the EARLY history - from the 20F filed in 2000.
All this took place prior to the break up of the original board where Dr Roberge had to buy back the IP and the name for 7.5m.
MRES corporate history...for those that like the detail..
CORPORATE BACKGROUND
The Company was created through articles of amalgamation filed pursuant to the
provisions of the Business Corporations Act (Ontario) 1990, on September 21,
1995, upon the amalgamation of two predecessor companies, Winteroad Resources
Limited and PenStar Wirecom, Ltd.
On December 10, 1997, the Company became the subject of a reverse takeover by
two Canadian companies, Neuro-Biotech Inc. ("NBI") and 1246895 Ontario Inc., and
changed its name to Neuro-Biotech Corporation. On April 27, 1998,
Neuro-Biotech's common shares began trading on the Canadian Dealing Network
under the symbol, "NBIO."
The executive offices of the Company are located at 1020 Route de l'Eglise,
Suite 600, Sainte-Foy, Quebec, G1V 3V9.
NEURO-BIOTECH INC.
NBI is the Company's operating subsidiary. NBI was founded to capitalize upon
the technological base that had been established by its founder, Dr. Andree G.
Roberge. Dr. Roberge conducted research at Laval University for over 20 years,
focusing on stress mechanisms, with particular emphasis on the relationship
between the brain and the whole body. During that period, Dr. Roberge, using a
series of therapeutic molecules, developed kits that could aid in increasing the
health and well-being of individuals suffering from stress-related and
neuroscience-based diseases.
In 1979, Dr. Roberge was invited by the National Research Council of Canada to
participate in a study on the mechanisms related to stress after cold exposure.
Soon after this study, Dr. Roberge focused on the mechanisms involving the HPAS
axis. This research provided the scientific foundation for Neuro-Biotech.
In 1982, Dr. Roberge developed a neurochemical experimental model for neurologic
diseases, including Alzheimer's and Schizophrenia. By 1985, Dr. Roberge had
characterized a bio-indicator and started to develop a new diagnostic tool to
measure stress levels. This breakthrough served as the basis for Neuro-Biotech's
first diagnostic kit, SymPath-TM-. In 1986, pre-clinical studies began for the
Company's first three diagnostics kits.
In 1988, Logilab Inc. ("Logilab") was formed to concretely develop and
commercialize the results of the research done by Dr. Roberge at Laval
University. Logilab was incorporated under Part 1A of the Companies Act (Quebec)
by articles of incorporation dated November 22, 1988. By articles of amendment
dated July 23, 1996, Logilab changed its corporate name to Neuro-Biotech Inc.
2
20FR12G 8th Page of 81 TOC 1st Previous Next Bottom Just 8th
In 1997, NBI acquired the intellectual property related to its diagnostic kit
technology platform from Laval University for the amount of $3,000,000 payable
in the form of a royalty at a rate of 3.5% of the Company's gross sales
revenues, with no specified due date.
We all must decide what to do based on what we believe to be true as presented on this board. This board is like a courtroom where all the evidence is presented and the investor is a member of the jury
This Andree Roberge?
andree roberge
VP - Scientific and clinical affairs chez Neuro-Biotech Corp
Contracting with a company, like Davinci, for virtual office support is a smart cost saving move for a development stage company IMO.
In terms of who they chose, i think going with Divinci was smart
8/25/2010
Davinci Virtual Office Solutions awarded Inc. 500 # 141
Inc. Magazine announced its 29th annual Inc. 500 ranking of the fastest-growing private companies in the country. Davinci Virtual, a leading provider of global turn-key virtual office solutions, ranks No. 141 on the list, with an extraordinary three-year revenue growth of 1,899.5% percent. The complete Inc. 500 list will be available in the September 2010 edition of Inc. Magazine.
Our corporation headquarters is based in Basel, Switzerland, closer to our target market, the "Big Pharma." Initially, this office will be available in its simplest form, but will contain the necessary facilities for various professional groups to hold meetings and negotiations.
ok - see you
Likewise.
In the prior PR there were many aspects of the new business plan discussed - all were prefaced as coming in the next few months...
so we wait and see.
Im pleased with have i have seen so far - which is verifiable steps toward the new corporate structure. NOw, if we get the ok from Finra without too much delay we should be under the new trading symbol soon with the old DMGM as sub.
One step at a time.
well first guess would be the lender mentioned in the PR
Contact Mike with your open questions - i've had mine answered.
They're acquiring revenue producing businesses. That's the plan going forward, trade non-performing for performing.
...whilst not diluting our class A common - current float 3.75m. o/s approx. 31m.
Progress being made.